The European Research Council (ERC) has selected a project from the National Cancer Research Centre (CNIO) to develop new drugs aimed at improving the efficacy of immunotherapy in different types of cancer.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The European Research Council (ERC) has selected a project from the National Cancer Research Centre (CNIO) to develop new drugs aimed at improving the efficacy of immunotherapy in different types of cancer.